Royal Bank of Canada
MDXG icon

Royal Bank of Canada’s MiMedx Group MDXG Stock Holding History

Royal Bank of Canada’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109K Sell
27,468
-186,366
-87% -$939K ﹤0.01% 5070
2025
Q4 		$1.45M Sell
213,834
-253,030
-54% -$1.77M ﹤0.01% 3369
2025
Q3 		$3.26M Sell
466,864
-471,849
-50% -$3.28M ﹤0.01% 3016
2025
Q2 		$5.74M Sell
938,713
-43,819
-4% -$291K ﹤0.01% 2459
2025
Q1 		$7.47M Buy
982,532
+13,629
+1% +$114K ﹤0.01% 1961
2024
Q4 		$9.32M Sell
968,903
-106,197
-10% -$827K ﹤0.01% 1841
2024
Q3 		$6.35M Sell
1,075,100
-416,965
-28% -$2.76M ﹤0.01% 2101
2024
Q2 		$10.3M Buy
1,492,065
+226,146
+18% +$1.59M ﹤0.01% 1657
2024
Q1 		$9.75M Buy
1,265,919
+186,822
+17% +$1.5M ﹤0.01% 1699
2023
Q4 		$9.46M Buy
1,079,097
+253,737
+31% +$1.86M ﹤0.01% 1758
2023
Q3 		$6.02M Buy
825,360
+813,478
+6,846% +$6.06M ﹤0.01% 1961
2023
Q2 		$79K Buy
11,882
+5,515
+87% +$28.1K ﹤0.01% 5508
2023
Q1 		$22K Sell
6,367
-8,986
-59% -$34.8K ﹤0.01% 5993
2022
Q4 		$42K Buy
15,353
+11,477
+296% +$34.3K ﹤0.01% 5985
2022
Q3 		$11K Sell
3,876
-275,619
-99% -$980K ﹤0.01% 6387
2022
Q2 		$970K Sell
279,495
-36,093
-11% -$141K ﹤0.01% 3540
2022
Q1 		$1.49M Sell
315,588
-94,963
-23% -$464K ﹤0.01% 3315
2021
Q4 		$2.48M Buy
410,551
+8,003
+2% +$55.6K ﹤0.01% 2965
2021
Q3 		$2.44M Buy
402,548
+114,820
+40% +$1.29M ﹤0.01% 2911
2021
Q2 		$3.6M Buy
287,728
+7,083
+3% +$76.7K ﹤0.01% 2543
2021
Q1 		$2.89M Buy
280,645
+101,442
+57% +$980K ﹤0.01% 2711
2020
Q4 		$1.63M Buy
+179,203
New +$1.29M ﹤0.01% 3103
2018
Q4 		– Sell
-289,991
Closed -$1.79M – 6964
2018
Q3 		$1.79M Sell
289,991
-644,873
-69% -$2.91M ﹤0.01% 2922
2018
Q2 		$5.97M Buy
934,864
+327,013
+54% +$2.33M ﹤0.01% 1891
2018
Q1 		$4.24M Buy
607,851
+313,657
+107% +$3.65M ﹤0.01% 2122
2017
Q4 		$3.71M Buy
294,194
+68,390
+30% +$834K ﹤0.01% 2264
2017
Q3 		$2.68M Sell
225,804
-1,461
-0.6% -$21.7K ﹤0.01% 2434
2017
Q2 		$3.4M Sell
227,265
-66,473
-23% -$887K ﹤0.01% 2209
2017
Q1 		$2.8M Buy
293,738
+31,672
+12% +$267K ﹤0.01% 2299
2016
Q4 		$2.32M Buy
262,066
+56,312
+27% +$506K ﹤0.01% 2474
2016
Q3 		$1.77M Buy
205,754
+35,583
+21% +$282K ﹤0.01% 2639
2016
Q2 		$1.36M Buy
170,171
+151,440
+808% +$1.18M ﹤0.01% 2849
2016
Q1 		$164K Sell
18,731
-419
-2% -$3.48K ﹤0.01% 4485
2015
Q4 		$179K Sell
19,150
-4,076
-18% -$35.3K ﹤0.01% 4595
2015
Q3 		$224K Sell
23,226
-1,311
-5% -$13.8K ﹤0.01% 4223
2015
Q2 		$285K Buy
24,537
+2,306
+10% +$23.7K ﹤0.01% 4085
2015
Q1 		$231K Sell
22,231
-5,200
-19% -$48.7K ﹤0.01% 4132
2014
Q4 		$316K Hold
27,431
– – ﹤0.01% 3985
2014
Q3 		$196K Buy
27,431
+1,500
+6% +$10.5K ﹤0.01% 4201
2014
Q2 		$184K Buy
25,931
+559
+2% +$3.27K ﹤0.01% 4220
2014
Q1 		$156K Buy
25,372
+10,372
+69% +$76.2K ﹤0.01% 4284
2013
Q4 		$131K Sell
15,000
-3,000
-17% -$18.4K ﹤0.01% 4429
2013
Q3 		$75K Buy
+18,000
New +$99.2K ﹤0.01% 4625

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Royal Bank of Canada's MDXG Position: Q1 2026 in Review

Royal Bank of Canada reduced its MiMedx Group (MDXG) stake by 87% in Q1 2026, selling an estimated $939K and leaving 27,468 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #5070.

Royal Bank of Canada first reported a position in MDXG in Q3 2013 and has held it in 43 quarters since. The position peaked at $10.3M in Q2 2024. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Royal Bank of Canada held 27,468 shares of MiMedx Group worth $109K as of Q1 2026.
  • Royal Bank of Canada sold 186,366 MiMedx Group shares in Q1 2026, an estimated $939K.
  • MiMedx Group made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5070 holding.
  • Royal Bank of Canada first reported a position in MiMedx Group in Q3 2013 and has held it in 43 quarters since.
  • Royal Bank of Canada's MiMedx Group position peaked at $10.3M in Q2 2024.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.